Total Payments
$8,152
2024 Payments
$1,157
Companies
43
Transactions
482
Medicare Patients
5,481
Medicare Billing
$643,819
Payment Breakdown by Category
Food & Beverage$8,150 (100.0%)
Education$1.95 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,150 | 481 | 100.0% |
| Education | $1.95 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,707 | 56 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $761.65 | 50 | $0 (2024) |
| ABBVIE INC. | $624.70 | 43 | $0 (2024) |
| PFIZER INC. | $611.18 | 58 | $0 (2024) |
| Daiichi Sankyo Inc. | $549.92 | 26 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $520.84 | 29 | $0 (2023) |
| Purdue Pharma L.P. | $367.58 | 28 | $0 (2018) |
| SCILEX PHARMACEUTICALS INC. | $332.96 | 17 | $0 (2024) |
| Amgen Inc. | $267.45 | 15 | $0 (2022) |
| Lilly USA, LLC | $254.04 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,157 | 47 | Boston Scientific Corporation ($424.84) |
| 2023 | $772.09 | 35 | Boston Scientific Corporation ($224.96) |
| 2022 | $906.42 | 49 | ABBVIE INC. ($204.55) |
| 2021 | $1,014 | 70 | Collegium Pharmaceutical, Inc. ($172.79) |
| 2020 | $822.54 | 52 | Collegium Pharmaceutical, Inc. ($162.59) |
| 2019 | $1,050 | 57 | Boston Scientific Corporation ($438.96) |
| 2018 | $1,094 | 78 | Boston Scientific Corporation ($266.38) |
| 2017 | $1,336 | 94 | Daiichi Sankyo Inc. ($373.14) |
All Payment Transactions
482 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Analgesic | ||||||
| 12/02/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.86 | General |
| Category: Opioid Analgesic | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Analgesic | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $23.34 | General |
| 10/08/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Analgesic | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Analgesic | ||||||
| 09/04/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.18 | General |
| Category: Opioid Analgesic | ||||||
| 08/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: PAIN | ||||||
| 08/20/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.17 | General |
| Category: Opioid Analgesic | ||||||
| 08/06/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Analgesic | ||||||
| 08/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.88 | General |
| Category: Opioid Analgesic | ||||||
| 07/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Analgesic | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Gastroenterology | ||||||
| 06/12/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Analgesic | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Gastroenterology | ||||||
| 05/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Analgesic | ||||||
| 05/14/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.45 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,129 | 2,378 | $697,167 | $125,368 |
| 2022 | 19 | 1,301 | 2,714 | $807,355 | $147,385 |
| 2021 | 20 | 1,415 | 2,996 | $945,147 | $185,750 |
| 2020 | 22 | 1,636 | 3,379 | $1.0M | $185,316 |
Total Patients
5,481
Total Services
11,467
Medicare Billing
$643,819
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 219 | 508 | $73,660 | $41,392 | 56.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 257 | 646 | $63,954 | $35,176 | 55.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 123 | 183 | $302,500 | $17,930 | 5.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $19,209 | $8,813 | 45.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 23 | 41 | $41,037 | $5,402 | 13.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 25 | 42 | $44,268 | $4,065 | 9.2% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 24 | 41 | $37,228 | $2,299 | 6.2% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 21 | 26 | $5,720 | $2,011 | 35.2% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 35 | 47 | $39,245 | $1,706 | 4.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 22 | 40 | $18,818 | $1,612 | 8.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 23 | 39 | $7,800 | $1,455 | 18.7% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 11 | 13 | $9,100 | $1,001 | 11.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 64 | 88 | $3,784 | $756.69 | 20.0% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 16 | 18 | $3,600 | $645.39 | 17.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 28 | 52 | $11,440 | $460.32 | 4.0% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Facility | 2023 | 27 | 43 | $9,460 | $334.97 | 3.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 79 | 333 | $3,330 | $257.11 | 7.7% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 51 | 137 | $3,014 | $52.58 | 1.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 248 | 590 | $85,622 | $46,972 | 54.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 295 | 791 | $78,309 | $44,391 | 56.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 142 | 212 | $353,024 | $20,935 | 5.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 80 | 80 | $17,493 | $9,106 | 52.1% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 33 | 52 | $52,811 | $7,155 | 13.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 31 | 53 | $51,119 | $4,782 | 9.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2022 | 30 | 52 | $42,816 | $2,771 | 6.5% |
About Dr. Patrick Goodman, MD
Dr. Patrick Goodman, MD is a Pain Medicine healthcare provider based in Tifton, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639392558.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Goodman, MD has received a total of $8,152 in payments from pharmaceutical and medical device companies, with $1,157 received in 2024. These payments were reported across 482 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($8,150).
As a Medicare-enrolled provider, Goodman has provided services to 5,481 Medicare beneficiaries, totaling 11,467 services with total Medicare billing of $643,819. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Tifton, GA
- Active Since 04/10/2007
- Last Updated 04/07/2021
- Taxonomy Code 208VP0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639392558
Products in Payments
- XTAMPZA (Drug) $673.84
- SPECTRA WAVEWRITER (Device) $557.10
- UBRELVY (Drug) $384.89
- LYRICA (Drug) $363.95
- Movantik (Drug) $331.05
- QULIPTA (Drug) $301.72
- Morphabond ER (Drug) $280.01
- Aimovig (Biological) $267.45
- ZTLido (Drug) $263.05
- GENERAL PAIN MANAGEMENT (Device) $260.88
- EMGALITY (Drug) $254.04
- AJOVY (Biological) $246.54
- NURTEC ODT (Drug) $234.85
- RELISTOR (Drug) $224.98
- Amitiza (Drug) $199.58
- AJOVY (Drug) $193.69
- Superion Indirect Decompression System (Device) $182.09
- SYMPROIC (Drug) $172.33
- GRALISE (Drug) $165.90
- Dayvigo (Drug) $120.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.